Yale New Haven Health is among the first healthcare systems in the country to transport critically ill patients using the ...
Medtronic's stock lags peers due to growth challenges in the diabetes and hypertension markets. See why we recommend a sell ...
Bogle, Medtronic’s head of medical affairs for digital surgery, also discussed the company’s plans to train surgeons for its ...
Boston Scientific is reaping the rewards from the energised PFA market opportunity in atrial fibrillation treatment.
15h
Hosted on MSNMedtronic Stock: Is Wall Street Bullish or Bearish?Galway, Ireland-based Medtronic plc (MDT) develops, manufactures, and sells device-based medical therapies to healthcare ...
17h
Hosted on MSNOrchestra BioMed Welcomes Christopher Cleary to Board of DirectorsNEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has announced the appointment of Christopher Cleary as an ...
The first-in-human SCS trial saw all three SMA patients able to increase their walking distance within six minutes to 20 meters.
Dividend aristocrat stocks have largely done well in the past few years. The closely-followed ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has jumped by over 133% from its lowest level in 2020.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results